A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets

Journal of Experimental Medicine

Volumn 190, Issue 8, 1999, Pages 1135-1145

  Grey, Shane T ^a   Arvelo, Maria B ^a   Hasenkamp, Wendy ^b   Bach, Fritz H ^a   Ferran, Christiane ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Joslin Diabetes Institute   (United States)

Author keywords

cells; A20; Apoptosis; Nitric oxide; Nuclear factor B

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL PROTECTION; GENE ACTIVATION; GENE THERAPY; GENE TRANSFER; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE; CYTOKINES; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NUCLEAR PROTEINS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 0032745109     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.8.1135     Document Type: Article

References (89)

1. Benoist, C., and D. Mathis. 1997. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell. 89:1-3.
2. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93:2260-2263.
3. Delovitch, T.L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 7:727-738.
4. Cameron, M.J., C. Meagher, and T.L. Delovitch. 1998. Failure in immune regulation begets IDDM in NOD mice. Diab. Metab. Rev. 14:177-185.
5. Mauricio, D., and T. Mandrup-Poulsen. 1998. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes. 47:1537-1543.
6. Kurrer, M.O., S.V. Pakala, H.L. Hanson, and J.D. Katz. 1997. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:213-218.
7. Kagi, D., B. Odermatt, P. Seiler, R.M. Zinkernagel, T.W. Mak, and H. Hengartner. 1997. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186:989-997.
8. Chervonsky, A.V., Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway, Jr., and L.A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
9. Arnush, M., M.R. Heitmeier, A.L. Scarim, M.H. Marino, P.T. Manning, and J.A. Corbett. 1998. IL-1 produced and released endogenously within human islets inhibits beta cell function. J. Clin. Invest. 102:516-526.
10. Heitmeier, M.R., A.L. Scarim, and J.A. Corbett. 1997. Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272:13697-13704.
11. Xie, Q., and C. Nathan. 1994. The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56:576-582.
12. Xia, Y., L.J. Roman, B.S. Masters, and J.L. Zweier. 1998. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J. Biol. Chem. 273:22635-22639.
13. Kaneto, H., J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes. 44:733-738.
14. Ankarcrona, M., J.M. Dypbukt, B. Brune, and P. Nicotera. 1994. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213:172-177.
15. Stassi, G., R.D. Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193-1200.
16. Takamura, T., I. Kato, N. Kimura, T. Nakazawa, H. Yonekura, S. Takasawa, and H. Okamoto. 1998. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic β cells develop insulin-dependent diabetes without insulitis. J. Biol. Chem. 273:2493-2496.
17. Reckard, C.R., F.P. Stuart, and J.A. Schulak. 1979. Immunologic comparisons of isolated pancreatic islet and whole-organ allografts. Transplant. Proc. 11:563-566.
18. Ballinger, W. 1976. Proceedings: Isolation and transplantation of islets of Langerhans in rat and monkey. Ann. R. Coll. Surg. Engl. 58:327-330.
19. Lacy, P.E., and J.M. Davie. 1984. Transplantation of pancreatic islets. Annu. Rev. Immunol. 2:183-198.
20. Weir, G.C., and S. Bonner-Weir. 1998. Islet transplantation as a treatment for diabetes. J. Am. Optom. Assoc. 69:727-732.
21. Bottino, R., L.A. Fernandez, C. Ricordi, R. Lehmann, M.F. Tsan, R. Oliver, and L. Inverardi. 1998. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes. 47:316-323.
22. Davalli, A.M., L. Scaglia, D.H. Zangen, J. Hollister, S. Bonner-Weir, and G.C. Weir. 1995. Early changes in syngeneic islet grafts: effect of recipient's metabolic control on graft outcome. Transplant. Proc. 27:3238-3239.
23. Davalli, A.M., L. Scaglia, D.H. Zangen, J. Hollister, S. Bonner-Weir, and G.C. Weir. 1996. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes. 45:1161-1167.
24. Efrat, S. 1998. Prospects for gene therapy of insulin-dependent diabetes mellitus. Diabetologia. 41:1401-1409.
25. Opipari, A.J., M.S. Boguski, and V.M. Dixit. 1990. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. 265:14705-14708.
26. Opipari, A.J., H.M. Hu, R. Yabkowitz, and V.M. Dixit. 1992. The A20 zinc finger protein protects cells from TNF cytotoxicity. J. Biol. Chem. 267:12424-12427.
27. Cooper, J.T., D.M. Stroka, C. Brostjan, A. Palmetshofer, F.H. Bach, and C. Ferran. 1996. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J. Biol. Chem. 271:18068-18073.
28. Ferran, C., D.M. Stroka, A.Z. Badrichani, J.T. Cooper, C.J. Wrighton, M. Soares, S.T. Grey, and F.H. Bach. 1998. A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91: 2249-2258.
29. D'Ambra, R., M. Surana, S. Efrat, R.G. Starr, and N. Fleischer. 1990. Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells. Endocrinology. 126:2815-2822.
30. Lowenstein, C.J., E.W. Alley, P. Raval, A.M. Snowman, S.H. Snyder, S.W. Russell, and W.J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:9730-9734.
31. Dyer, R.B., and N.K. Herzog. 1995. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. Biotechniques. 19:192-195.
32. O'Brien, B.A., B.V. Harmon, D.P. Cameron, and D.J. Allan. 1996. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J. Pathol. 178:176-181.
33. Corbett, J.A., J.R. Lancaster, Jr., M.A. Sweetland, and M.L. McDaniel. 1991. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1β-induced inhibition of insulin secretion. J. Biol. Chem. 266:21351-21354.
34. Kwon, G., J.A. Corbett, C.P. Rodi, P. Sullivan, and M.L. McDaniel. 1995. Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: evidence for the involvement of nuclear factor κB in the signaling mechanism. Endocrinology. 136:4790-4795.
35. Lorsbach, R.B., W.J. Murphy, C.J. Lowenstein, S.H. Snyder, and S.W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 268:1908-1913.
36. Taylor, B.S., M.E. de Vera, R.W. Ganster, Q. Wang, R.A. Shapiro, S.M. Morris, Jr., T.R. Billiar, and D.A. Geller. 1998. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 24:15148-15156.
37. Baeuerle, P.A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science. 242:540-546.
38. Traenckner, E.B., H.L. Pahl, T. Henkel, K.N. Schmidt, S. Wilk, and P.A. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO (Eur. Mol. Biol. Organ.) J. 14:2876-2883.
39. Efrat, S., G. Fejer, M. Brownlee, and M.S. Horwitz. 1995. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc. Natl. Acad. Sci. USA. 92:6947-6951.
40. Welsh, N., B. Margulis, L.A. Borg, H.J. Wiklund, J. Saldeen, M. Flodstrom, M.A. Mello, A. Andersson, D.G. Pipeleers, C. Hellerstrom, et al. 1995. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol. Med. 1:806-820.
41. Tiedge, M., S. Lortz, J. Drinkgern, and S. Lenzen. 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 46:1733-1742.
42. Hu, X., E. Yee, J.M. Harlan, F. Wong, and A. Karsan. 1998. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood. 92:2759-2765.
43. Sarma, V., Z. Lin, L. Clark, B.M. Rust, M. Tewari, R.J. Noelle, and V.M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343-12346.
44. Laherty, C.D., H.M. Hu, A.W. Opipari, F. Wang, and V.M. Dixit. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating NF-κB. J. Biol. Chem. 267:24157-24160.
45. Laherty, C.D., N.D. Perkins, and V.M. Dixit. 1993. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J. Biol. Chem. 268:5032-5039.
46. Krikos, A., C.D. Laherty, and V.M. Dixit. 1992. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267:17971-17976.
47. Bach, F.H., W.W. Hancock, and C. Ferran. 1997. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol. Today. 18:483-486.
48. Arnush, M., A.L. Scarim, M.R. Heitmeier, C.B. Kelly, and J.A. Corbett. 1998. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Immunol. 160:2684-2691.
49. Ling, Z., M.C. Chen, A. Smismans, D. Pavlovic, F. Schuit, D.L. Eizirik, and D.G. Pipeleers. 1998. Intercellular differences in interleukin 1β-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic β-cells. Endocrinology. 139:1540-1545.
50. Ma, Z., M. Landt, A. Bohrer, S. Ramanadham, D.M. Kipnis, and J. Turk. 1997. Interleukin-1 reduces the glycolytic utilization of glucose by pancreatic islets and reduces glucokinase mRNA content and protein synthesis by a nitric oxide-dependent mechanism. J. Biol. Chem. 272:17827-17835.
51. Cailleau, C., A. Diu-Hercend, E. Ruuth, R. Westwood, and C. Carnaud. 1997. Treatment with neutralizing antibodies specific for IL-1β prevents cyclophosphamide-induced diabetes in nonobese diabetic mice. Diabetes. 46:937-940.
52. Jun, H.S., P. Santamaria, H.W. Lim, M.L. Zhang, and J.W. Yoon. 1999. Absolute requirement of macrophages for the development and activation of β-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes. 48:34-42.
53. Jun, H.S., C.S. Yoon, L. Zbytnuik, N. van Rooijen, and J.W. Yoon. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189:347-358.
54. Rabinovitch, A., W.L. Suarez-Pinzon, O. Sorensen, and R.C. Bleackley. 1996. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology. 137:2093-2099.
55. Corbett, J.A., M.A. Sweetland, J.L. Wang, J.R. Lancaster, Jr., and M.L. McDaniel. 1993. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA. 90:1731-1735.
56. Delaney, C.A., D. Pavlovic, A. Hoorens, D.G. Pipeleers, and D.L. Eizirik. 1997. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology. 138:2610-2614.
57. Wilson, G.L., N.J. Patton, and S.P. LeDoux. 1997. Mitochondrial DNA in beta-cells is a sensitive target for damage by nitric oxide. Diabetes. 46:1291-1295.
58. Corbett, J.A., and M.L. McDaniel. 1992. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes. 41:897-903.
59. Loweth, A.C., G.T. Williams, R.F. James, J.H. Scarpello, and N.G. Morgan. 1998. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1β and Fas ligation. Diabetes. 47:727-732.
60. Xie, Q.W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
61. Yang, X.D., S.A. Michie, R.E. Mebius, R. Tisch, I. Weissman, and H.O. McDevitt. 1996. The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy. Diabetes. 45:705-710.
62. Zeng, Y., A. Gage, A. Montag, R. Rothlein, J. Thistlethwaite, and J. Bluestone. 1994. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 58:681-689.
63. Gao, J., D.C. Morrison, T.J. Parmely, S.W. Russell, and W.J. Murphy. 1997. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J. Biol. Chem. 272:1226-1230.
64. Martin, E., C. Nathan, and Q.W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
65. Yeong-Song, H., M. Rothe, and D.V. Goeddel. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF-1/TRAF-2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. USA. 93:6721-6725.
66. Vincenz, C., and V.M. Dixit. 1996. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271:20029-20034.
67. Heyninck, K., and R. Beyaert. 1999. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κD activation at the level of TRAF6. FEBS Lett. 442:147-150.
68. Tzivion, G., Z. Luo, and J. Avruch. 1998. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature. 394:88-92.
69. Cao, Z., W.J. Henzel, and X. Gao. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1128-1131.
70. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature. 383:443-446.
71. Lomaga, M.A., W.C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.
72. Schreck, R., P. Rieber, and P.A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO (Eur. Mol. Biol. Organ.) J. 10:2247-2258.
73. Ferran, C., M.T. Millan, V. Csizmadia, J.T. Cooper, C. Brostjan, F.H. Bach, and H. Winkler. 1995. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun. 214:212-223.
74. Kubisch, H.M., J. Wang, T.M. Bray, and J.P. Phillips. 1997. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress. Diabetes. 46:1563-1566.
75. Benhamou, P.Y., C. Moriscot, M.J. Richard, O. Beatrix, L. Badet, F. Pattou, J. Kerr-Conte, J. Chroboczek, P. Lemarchand, and S. Halimi. 1998. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia. 41:1093-1100.
76. Hohmeier, H.E., A. Thigpen, V.V. Tran, R. Davis, and C.B. Newgard. 1998. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest. 101:1811-1820.
77. Hotta, M., F. Tashiro, H. Ikegami, H. Niwa, T. Ogihara, J. Yodoi, and J. Miyazaki. 1998. Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188:1445-1451.
78. Jin, D.Y., H.Z. Chae, S.G. Rhee, and K.T. Jeang. 1997. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J. Biol. Chem. 272:30952-30961.
79. Kim, I.Y., and T.C. Stadtman. 1997. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc. Natl. Acad. Sci. USA. 94:12904-12907.
80. O'Brien, B.A., B.V. Harmon, D.P. Cameron, and D.J. Allan. 1997. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes. 46:750-757.
81. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science. 257:789-792.
82. Benhamou, P.Y., C. Moriscot, L. Badet, and S. Halimi. 1998. Strategies for graft immunomodulation in islet transplantation. Diab. Metab. 24:215-224.
83. Kendall, D.M., and R.P. Robertson. 1996. Pancreas and islet transplantation in humans. Diab. Metab. 22:157-163.
84. Stratta, R.J. 1998. Immunosuppression in pancreas transplantation: progress, problems and perspective. Transpl. Immunol. 6:69-77.
85. Iwahashi, H., T. Hanafusa, Y. Eguchi, H. Nakajima, J. Miyagawa, N. Itoh, K. Tomita, M. Namba, M. Kuwajima, T. Noguchi, et al. 1996. Cytokine-induced apoptotic cell death in a mouse pancreatic β-cell line: inhibition by Bcl-2. Diabetologia. 39:530-536.
86. Liu, Y., A. Rabinovitch, W. Suarez-Pinzon, B. Muhkerjee, M. Brownlee, D. Edelstein, and H.J. Federoff. 1996. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic β-cells from apoptosis. Hum. Gene Ther. 7:1719-1726.
87. Shibasaki, F., E. Kondo, T. Akagi, and F. McKeon. 1997. Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:728-731.
88. Stroka, D.M., A.Z. Badrichani, F.H. Bach, and C. Ferran. 1999. Overexpression of A1, an NF-κB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. Blood. 93: 3803-3810.
89. Badrichani, A.Z., D.M. Stroka, G. Bilbao, D.T. Curiel, F.H. Bach, and C. Ferran. 1999. Bcl-2 and Bcl-XL serve an antiinflammatory function in endothelial cells through inhibition of NF-κB. J. Clin. Invest. 103:543-553.